Goldman Urology recently announced that it has adopted URO dot AI, an AI-powered software that automatically analyzes non-contrast CT images to detect the presence, size, and location of urinary stones.

Previously, urology specialists had to manually review each patient’s CT image, a time-consuming process with the risk of missing small stones. URO dot AI, however, produces results within five minutes, enhancing both the speed and accuracy of patient diagnosis.

URO dot AI conducts a full anatomical analysis of the urinary tract, including the ureters, kidneys, and bladder, and can detect even small stones under 4 mm that are difficult to identify manually. It also displays the stones’ location and size in real time, aiding in treatment planning.

From the patient perspective, the system improves diagnostic convenience. Rapid interpretation allows faster pain relief in emergencies, while precise localization and measurement reduce unnecessary follow-up tests and invasive procedures. Furthermore, small stones that may be missed by conventional X-ray or ultrasound can be detected, enabling early diagnosis and treatment.

Clinical trials of URO dot AI have demonstrated excellent performance. In the primary efficacy evaluation, it achieved a sensitivity of 97.89% and specificity of 94.12%. In the secondary evaluation, sensitivity reached 98.82% and specificity 96.67%, with 100% accuracy for stones larger than 5 mm in diameter.

Importantly, URO dot AI has been officially recognized as an innovative medical technology by the Ministry of Health and Welfare, confirming its safety and efficacy.

A representative from Goldman Urology stated,
“URO dot AI is a technology that brings new diagnostic capabilities to our workflow. We will continue to provide patients with more precise and systematic care.”

Medical Today / September 3, 2025 / Reporter Minseok Choi